SANUWAVE Health (SNWV) Non-Current Debt (2010 - 2026)

SANUWAVE Health (SNWV) posted quarterly Non-Current Debt of $14.3 million for Q1 2026, down 8.53% quarter-over-quarter from $15.7 million in Q4 2025.

SANUWAVE Health (SNWV) Non-Current Debt (2010 - 2026) Analysis & Trends

SANUWAVE Health (SNWV) has reported Non-Current Debt for 12 consecutive years, with $14.3 million the latest figure, recorded in Q1 2026.

In Q1 2026, Non-Current Debt changed N/A year-over-year to $14.3 million; the TTM figure through Mar 2026 stood at $14.3 million (changed N/A YoY), while the FY2025 annual figure was $15.7 million, changed N/A from the prior year.
Non-Current Debt declined to $14.3 million in Q1 2026 per SNWV's latest filing, from $15.7 million in the prior quarter.
Across five years, Non-Current Debt topped out at $23.3 million in Q3 2025 and bottomed at $761000.0 in Q2 2022.
Historically, Non-Current Debt has averaged $11.0 million across 3 years, with a median of $14.3 million in 2026.
On a YoY basis, Non-Current Debt climbed as much as 21.88% in 2022 and fell as far as 24.73% in 2022.
SANUWAVE Health's Non-Current Debt stood at $761000.0 in 2022, then soared by 1958.74% to $15.7 million in 2025, then decreased by 8.53% to $14.3 million in 2026.
Business Quant data shows SNWV's Non-Current Debt at $14.3 million in Q1 2026, $15.7 million in Q4 2025, and $23.3 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Abbott Laboratories	201.66 Bn	196.06 Bn	7.27 Bn	29.60 Bn
2	Stryker	126.46 Bn	122.98 Bn	4.50 Bn	14.19 Bn
3	Medtronic	119.25 Bn	110.03 Bn	6.41 Bn	26.17 Bn
4	Boston Scientific	74.09 Bn	73.55 Bn	3.85 Bn	10.92 Bn
5	Edwards Lifesciences	51.93 Bn	47.68 Bn	1.35 Bn	598.70 Mn
6	Dexcom	34.67 Bn	32.72 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.81 Bn	31.70 Bn	2.18 Bn	10.09 Bn
8	Koninklijke Philips	26.29 Bn	22.97 Bn	4.55 Bn	7.34 Bn
9	Steris	23.20 Bn	22.72 Bn	684.20 Mn	1.65 Bn
10	SANUWAVE Health	42.06 Mn	32.68 Mn	7.42 Mn	12.92 Mn

Download Data